Clinical Trial Update: Donor-Derived Viral Specific T-cells (VSTs) for Prophylaxis Against Viral Infections After Allogeneic Stem Cell Transplant [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating donor-derived viral-specific T-cells to prevent viral infections after allogeneic stem cell transplantation has completed with posted r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allogeneic Stem Cell Transplantation Complication
• Viral Infection After Transplantation

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Allogeneic Stem Cell Transplant, Viral Infection | Phase 2 | Status: COMPLETED | Results posted: 2022-12-13